136 related articles for article (PubMed ID: 32971585)
1. KIF4A: A potential biomarker for prediction and prognostic of prostate cancer.
Chen J; Li M; Fang S; Zhou X; Liao J; Yang S; Zhu J; He R; Lu J; Jiang F; Xu X; Zhong W
Clin Invest Med; 2020 Sep; 43(3):E49-59. PubMed ID: 32971585
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
[TBL] [Abstract][Full Text] [Related]
3. Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
Song X; Zhang T; Wang X; Liao X; Han C; Yang C; Su K; Cao W; Gong Y; Chen Z; Han Q; Li J
Med Sci Monit; 2018 Dec; 24():9442-9464. PubMed ID: 30593585
[TBL] [Abstract][Full Text] [Related]
4. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.
Hou PF; Jiang T; Chen F; Shi PC; Li HQ; Bai J; Song J
Cell Death Dis; 2018 May; 9(5):477. PubMed ID: 29706624
[TBL] [Abstract][Full Text] [Related]
5. KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.
Zhang J; An L; Zhao R; Shi R; Zhou X; Wei S; Zhang Q; Zhang T; Feng D; Yu Z; Wang H
Mol Carcinog; 2023 Mar; 62(3):303-318. PubMed ID: 36468837
[TBL] [Abstract][Full Text] [Related]
6. Increased KIF4A expression is a potential prognostic factor in prostate cancer.
Gao H; Chen X; Cai Q; Shang Z; Niu Y
Oncol Lett; 2018 May; 15(5):7941-7947. PubMed ID: 29725481
[TBL] [Abstract][Full Text] [Related]
7. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
[TBL] [Abstract][Full Text] [Related]
8. KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
Zheng P; Wu K; Gao Z; Li H; Li W; Wang X; Shi Z; Xiao F; Wang K; Li Z; Han Q
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846765
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value and Immune-Infiltration Pattern of
Yang Z; Shen X; Luo S; Li Y
Dis Markers; 2022; 2022():9621701. PubMed ID: 35126794
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients.
Wu J; Li L; Zhong H; Zhang HH; Li J; Zhang HB; Zhao YQ; Xu B; Song QB
Curr Med Sci; 2022 Dec; 42(6):1273-1284. PubMed ID: 36260268
[TBL] [Abstract][Full Text] [Related]
11. High KIFC1 expression is associated with poor prognosis in prostate cancer.
Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
[TBL] [Abstract][Full Text] [Related]
12. KIF4A as a novel prognostic biomarker in cholangiocarcinoma.
Zhang DY; Ma SS; Sun WL; Lv XCH; Lu Z
Medicine (Baltimore); 2021 May; 100(21):e26130. PubMed ID: 34032761
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
14. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
16. An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.
Xue D; Cheng P; Han M; Liu X; Xue L; Ye C; Wang K; Huang J
Onco Targets Ther; 2018; 11():4755-4768. PubMed ID: 30127624
[TBL] [Abstract][Full Text] [Related]
17. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
Feng S; Luo S; Ji C; Shi J
World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
19. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
[TBL] [Abstract][Full Text] [Related]
20. EZH2 suppresses insulinoma development by epigenetically reducing KIF4A expression via H3K27me3 modification.
Zhang S; Liu J; Li F; Yang M; Wang J
Gene; 2022 May; 822():146317. PubMed ID: 35182680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
